AI assistant
Sending…
UPEXI, INC. — Director's Dealing 2021
Jun 24, 2021
33031_dirs_2021-06-24_d7b50055-58b5-4bca-868a-cf696012ea92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GROVE, INC. (GRVI)
CIK: 0001775194
Period of Report: 2021-06-24-05:00
Reporting Person: Salkind Gene (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2352941 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option Grant | $ | Common Stock (27778) | Direct |
Footnotes
F1: Subject to a 180-day lockup period in connection with the Issuer's initial public offering.
F2: 4,630 options are vested and shall be exercisable for a price of $1.53 per option share for 10 years from February 1, 2021 (the "Grant Date"). 23,148 options shall vest on a monthly basis over a one year period and be exercisable for a price of $1.53 per option share for ten years from the Grant Date.
More from UPEXI, INC.
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 11
Interim / Quarterly Report
2026
Feb 10
Regulatory Filings
2026
Feb 10
Regulatory Filings
2026
Feb 9
Regulatory Filings
2026
Feb 9
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4